FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

787994008: Antibacterial therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778326014 Antibacterial therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3778327017 Antibacterial therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antibacterial therapeutic role Is a Therapeutic role false Inferred relationship Existential restriction modifier
Antibacterial therapeutic role Is a Antiinfective therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefoperazone (as cefoperazone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefoperazone (as cefoperazone sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefoperazone (as cefoperazone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftizoxime (as ceftizoxime sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftizoxime (as ceftizoxime sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefoxitin (as cefoxitin sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely polymyxin B (as polymyxin B sulfate) 500000 unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tobramycin (as tobramycin sulfate) 1.2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mezlocillin (as mezlocillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mezlocillin (as mezlocillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mezlocillin (as mezlocillin sodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mezlocillin (as mezlocillin sodium) 4 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 60 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 775 milligram/1 each prolonged-release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram/1 each conventional release chewable tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor anhydrous (as cefaclor) 37.4 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor anhydrous (as cefaclor) 75 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftazidime anhydrous (as ceftazidime) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline anhydrous (as doxycycline) 75 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline anhydrous (as doxycycline) 5 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 4 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin anhydrous (as levofloxacin) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely doxycycline monohydrate 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefmetazole (as cefmetazole sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ampicillin and sulbactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only aztreonam in pulmonary dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only benzylpenicillin in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ciprofloxacin and dexamethasone in otic dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only dalbavancin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ertapenem in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only fluorometholone and tobramycin in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only fosfomycin in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only loteprednol and tobramycin in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only mafenide in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only tedizolid in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only telavancin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing doxycycline in oromucosal dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing mandelic acid in conventional release solution for irrigation (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing mezlocillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing piperacillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing ticarcillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fosfomycin (as fosfomycin tromethamine) 3 gram/1 sachet powder for conventional release oral solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only mandelic acid in conventional release solution for irrigation (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only mezlocillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only piperacillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ticarcillin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Antimycobacterial therapeutic role Is a True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cilastatin and imipenem and relebactam (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Cilastatin + Imipenem + Relebactam Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cilastatin and imipenem and relebactam in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing lefamulin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only lefamulin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing lefamulin in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing lefamulin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only lefamulin in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only lefamulin in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefiderocol (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Cefiderocol Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing cefiderocol in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only cefiderocol in parenteral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely silver sulfadiazine 10 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only silver sulfadiazine in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Sulfadiazine silver Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing sulfadiazine in cutaneous dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing amikacin liposome in pulmonary dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing minocycline in oromucosal dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin palmitate hydrochloride) 15 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzylpenicillin (as benzylpenicillin potassium) 5 million unit/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 17 of 27 Next End

This concept is not in any reference sets

Back to Start